Medical Hypotheses
Volume 73, Issue 5 , Pages 659-661, November 2009

Antifibrotic medication using a combination of N-acetyl-L-cystein (NAC) and ACE inhibitors can prevent the recurrence of Dupuytren’s disease

  • Karsten Knobloch

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Tel.: +49 511 532 8864; fax: +49 511 532 8890.
    • ,
  • Joern Redeker
    • ,
  • Peter M. Vogt

Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Germany

Received 3 August 2009; accepted 9 August 2009. published online 02 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(09)00561-1

doi:10.1016/j.mehy.2009.08.011

Medical Hypotheses
Volume 73, Issue 5 , Pages 659-661, November 2009

Article Tools